Introduction
This quiz set is designed for M.Pharm students studying Regulatory Aspects of Food & Nutraceuticals, focusing on international harmonization and market access considerations. The questions cover key global frameworks, guideline families, and regulatory strategies that impact cross-border trade and product approval — including Codex, ICH, PIC/S, mutual recognition agreements, novel food rules, and jurisdictional differences such as DSHEA and EFSA requirements. Emphasis is placed on practical dossier expectations (CTD/eCTD), stability/climate-zone considerations, GMP acceptance, claims substantiation, and market-entry documentation. Use these MCQs to test and deepen your understanding of how harmonized standards and regional requirements shape global nutraceutical regulatory pathways.
Q1. Which international body is responsible for developing the Codex Alimentarius standards for food safety and quality?
- World Health Organization (WHO)
- Food and Agriculture Organization (FAO)
- Codex Alimentarius Commission (CAC)
- International Council for Harmonisation (ICH)
Correct Answer: Codex Alimentarius Commission (CAC)
Q2. Which ICH guideline cluster defines the structure and content of the Common Technical Document (CTD)?
- ICH Q1 Series
- ICH M4 (CTD)
- ICH E6 (GCP)
- ICH S6 (Biotechnological)
Correct Answer: ICH M4 (CTD)
Q3. Which U.S. law established the regulatory framework specifically for dietary supplements?
- Federal Food, Drug, and Cosmetic Act (FD&C Act)
- Food Safety Modernization Act (FSMA)
- Dietary Supplement Health and Education Act (DSHEA) 1994
- Nutrition Labeling and Education Act (NLEA)
Correct Answer: Dietary Supplement Health and Education Act (DSHEA) 1994
Q4. Which EU regulation governs nutrition and health claims made on foods and supplements?
- Regulation (EC) No 178/2002 (General Food Law)
- Regulation (EC) No 1924/2006 on nutrition and health claims
- Regulation (EU) 2019/1381 on transparency
- Directive 2001/83/EC on medicinal products
Correct Answer: Regulation (EC) No 1924/2006 on nutrition and health claims
Q5. Which international arrangement focuses on harmonizing GMP inspection practices among national inspectorates?
- Codex Alimentarius Commission
- Mutual Recognition Agreement (MRA)
- Pharmaceutical Inspection Co-operation Scheme (PIC/S)
- World Trade Organization (WTO) SPS Committee
Correct Answer: Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Q6. In the CTD format, which module primarily contains pharmaceutical quality (CMC) information?
- Module 1 — Administrative Information
- Module 2 — Quality Overall Summary
- Module 3 — Quality (CMC)
- Module 5 — Clinical Study Reports
Correct Answer: Module 3 — Quality (CMC)
Q7. Which ICH guideline is the primary reference for stability testing and appropriate climatic conditions for stability studies?
- ICH Q3 (Impurities)
- ICH Q1A(R2) Stability Testing of New Drug Substances and Products
- ICH Q7 (GMP for APIs)
- ICH E2 (Pharmacovigilance)
Correct Answer: ICH Q1A(R2) Stability Testing of New Drug Substances and Products
Q8. What is the primary benefit of a Mutual Recognition Agreement (MRA) between regulatory authorities?
- Standardizes clinical trial design globally
- Allows mutual recognition of GMP inspection results and certificates
- Mandates identical labelling across countries
- Replaces national legislation with a single law
Correct Answer: Allows mutual recognition of GMP inspection results and certificates
Q9. In the EU, which regulatory pathway must be considered for nutraceutical ingredients not widely consumed before 1997?
- Authorization under Novel Food Regulation (EU) 2015/2283
- Simplified notification under DSHEA
- Marketing Authorization as a medicinal product
- Self-declaration to EFSA without assessment
Correct Answer: Authorization under Novel Food Regulation (EU) 2015/2283
Q10. What regulatory action is typically required in the U.S. before marketing a truly new dietary ingredient (NDI) in supplements?
- Full New Drug Application (NDA)
- New Dietary Ingredient (NDI) Notification to FDA
- Pre-market authorization by EFSA
- Registration with Codex Alimentarius
Correct Answer: New Dietary Ingredient (NDI) Notification to FDA
Q11. Which document commonly supports export and market access by certifying that a product is legally marketed in the exporting country?
- Certificate of Analysis (COA)
- Certificate of Pharmaceutical Product (CPP)
- Certificate of Free Sale (CFS)
- Good Distribution Practice (GDP) certificate
Correct Answer: Certificate of Free Sale (CFS)
Q12. Which ICH guideline series addresses pharmacovigilance and adverse event reporting that may be expected by multiple regulators?
- ICH Q series
- ICH M series
- ICH E2 (pharmacovigilance) series
- ICH S series
Correct Answer: ICH E2 (pharmacovigilance) series
Q13. When preparing claims for nutraceutical marketing in multiple jurisdictions, which factor most strongly determines acceptability?
- The product’s manufacturing site location
- The level and type of scientific evidence required by the target jurisdiction
- The tariff classification code
- The product’s color and packaging material
Correct Answer: The level and type of scientific evidence required by the target jurisdiction
Q14. PIC/S membership primarily helps national authorities by doing which of the following?
- Issuing marketing authorizations for foods
- Harmonizing GMP inspection standards and facilitating inspector training
- Setting global nutrition claim lists
- Providing trade dispute arbitration
Correct Answer: Harmonizing GMP inspection standards and facilitating inspector training
Q15. What electronic dossier format has become the international standard for regulatory submissions in many regions?
- PDF-only dossiers
- eCTD (electronic Common Technical Document)
- CSV data packages
- Paper CTD with handwritten cover letters
Correct Answer: eCTD (electronic Common Technical Document)
Q16. Which of the following is an example of a non-tariff barrier affecting nutraceutical market access?
- Import duty on finished products
- Sanitary and phytosanitary (SPS) measures and differing labeling rules
- Currency exchange rate fluctuations
- Shipping freight costs
Correct Answer: Sanitary and phytosanitary (SPS) measures and differing labeling rules
Q17. Importing countries sometimes waive local batch release testing based on what international arrangement or documentation?
- Presence of domestic manufacturing only
- Mutual Recognition Agreements or reliance on exporting country GMP certificates
- Lower declared product value
- Absence of product claims
Correct Answer: Mutual Recognition Agreements or reliance on exporting country GMP certificates
Q18. Which authority conducts scientific assessment of health claims for foods in the European Union?
- European Medicines Agency (EMA)
- European Food Safety Authority (EFSA)
- World Health Organization (WHO)
- Food and Agriculture Organization (FAO)
Correct Answer: European Food Safety Authority (EFSA)
Q19. For cross-border acceptance of stability data, what characteristic of the data is most important to importing regulators?
- Use of accelerated photostability only
- Data generated using climatic conditions and protocols accepted by the importing regulator (ICH zones)
- Data generated exclusively at a single low temperature
- Only in-vitro assay results without real-time data
Correct Answer: Data generated using climatic conditions and protocols accepted by the importing regulator (ICH zones)
Q20. Compared with pharmaceuticals, which market-access consideration is often different for nutraceuticals?
- Nutraceuticals universally require full clinical trials for safety
- Many jurisdictions treat nutraceuticals as foods requiring pre-market notification or post-market controls rather than full pre-market authorization like pharmaceuticals
- Nutraceuticals never require labeling statements
- Nutraceuticals are regulated only by the WTO
Correct Answer: Many jurisdictions treat nutraceuticals as foods requiring pre-market notification or post-market controls rather than full pre-market authorization like pharmaceuticals
